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Introduction
The methylation of the C-5 position of cytosine in genomic DNA resulting in the formation of 5-methyl-2′-deoxycytidine (5-MedC) attracts major research interest from all areas of the biological scientific community. [1] [2] [3] [4] [5] This epigenetic alteration plays an important role in many biological processes such as cellular differentiation, gene expression and maintaining genome integrity. [4, 5] Furthermore aberrant methylation has been found to be associated with carcinogenesis. [2, 3, 6] In particular global hypomethylation has been observed in various human cancers. [4, 7] In mammalian cells the majority of 5-MedC is located within 5′-CpG-3′ dinucleotide containing sequences. [1, 4, 5] The importance of 5-MedC has resulted in the development of numerous methods for the assessment of global methylation and also in site-specific sequences. Nonchromatographic methods used for the assessment of genomic DNA methylation include: the preferential conversion of unmethylated cytosine to uracil by sodium bisulphite and subsequent determination by PCR amplification and sequencing [2, 8] ; a radioactive assay which involves the de novo transfer of a radioactive methyl donor by DNA methyltransferase to 2′-deoxycytidine (dC) sites within the DNA [9] ; a Southern blot assay that utilises DNA digestion with restriction endonucleases that are sensitive to methylated sites [2, 10] ; an assay involving single nucleotide extension with radiolabelled [ 3 H]dCTP following cleavage of DNA with methylation-sensitive restriction endonucleases [11] . Chromatographic approaches include methods such as thin layer chromatography (following 32 P-postlabelling) [12, 13] , high performance liquid chromatography (HPLC) coupled to UV and mass spectrometric [14] [15] [16] [17] detection, gas chromatography [18, 19] and capillary electrophoresis [20] [21] [22] [23] [24] .
For the determination of 5-MedC in DNA by HPLC-UV detection the analyses are performed at the 2′-deoxynucleoside [25] [26] [27] [28] [29] [30] or 2′-deoxynucleotide [31, 32] level following enzymatic hydrolysis or at the nucleobase level following acid hydrolysis.
[ [33] [34] [35] [36] The latter is not a preferred option due to the potential of contamination from 5-methylcytosine derived from RNA that maybe present in the DNA sample which is also released by acid hydrolysis.
We describe the development of a HPLC-UV detection method for the determination of 5-MedC which has been applied to the analysis of 5-MedC content in calf thymus DNA, HeLa cell DNA and rat liver DNA following enzymatic hydrolysis to 2′-deoxynucleosides. 
Materials and Methods

Chemicals
Preparation of 2′-deoxynucleoside standard stock solutions
The 5-MedC and dC standard stock solutions were prepared dissolved in HPLC grade water. The concentration of each solution was calculated using the extinction coefficient following determination of the UV absorbance, for 5-MedC = 8,500 M -1 cm -1 at λ max 277 nm and dC = 9,000 M -1 cm -1 at λ max 271 nm (U-3010 spectrophotometer, Hitachi, Tokyo, Japan) [37] .
HeLa cells
HeLa cells were cultured in Dulbecco's Minimum Eagle Medium (DMEM), 
Animals
Male Wistar rats (8-10 weeks old, 350-475 g were purchased from Charles River Laboratories (Margate, UK)). The rats were control animals (administered corn oil by gavage) from a study previously conducted in our laboratory. The animals were culled 48 h following dosing with corn oil by exsanguination under halothane anaesthesia and the liver tissue was immediately frozen in liquid nitrogen following resection.
DNA extraction from HeLa cells
The DNA was extracted from the HeLa cells using the Qiagen kit (Qiagen Ltd., West Sussex, UK) which utilises an anion-exchange column procedure, as described in the instructions for the kit but with a few modifications. The cells were suspended in icecold buffer C1 (2 mL) and ice-cold HPLC grade water (6 mL) and mixed by inversion mg) and RNase T 1 (100 U) at 37 °C for 30 min which was followed by a further incubation at 37 °C with 500 L of proteinase K (25 mg/mL) for 2.5 h. The DNA was purified using the Midi Qiagen genomic tips (100/G) equilibrated with 4 mL of buffer QBT by gravity flow. The sample mixture was vortexed for 30 s and applied to the equilibrated Qiagen column which was then washed twice with 7.5 mL of buffer QC.
The DNA was eluted from the column with 5 mL of buffer QF (maintained at 37 °C).
Ice-cold isopropanol (0. was calculated by determining the absorbance at 260 nm (GeneQuant spectrophotometer, Biochrom, Cambridge, UK) assuming that one absorbance unit equals 50 g/mL for double stranded DNA. The samples were stored at -80ºC.
DNA extraction from animal tissue
The DNA was extracted from rat liver tissue using the Qiagen kit as described in the instructions for the kit but with a few modifications. Approximately 500 mg of tissue was homogenised using a Dounce homogeniser following suspension in 19 mL of G2 buffer solution. RNA contamination was removed by the addition of RNase A (2.5 mg) and RNase T 1 (100 U) at 37 °C for 30 min which was followed by a further incubation at 37 °C with 500 L of proteinase K (25 mg/mL) for 2. 
HPLC-UV detection
The hydrolysed DNA samples were analysed by injecting a 10 µL aliquot (equivalent 
Calibration lines for 5-MedC and dC
The calibration lines were constructed by the dilution of the stock standard solutions for 5-MedC (0.0625 to 10 nmol on column) and dC (0.125 to 25 nmol on column) which were used to determine level of 5-MedC and dC in the hydrolysed DNA samples.
Calculation of the percentage 5-MedC in DNA
The level of 5-MedC present in the DNA samples was expressed as a percentage of the level of dC which was calculated using the following equation: RNAse A hydrolysing at pyrimidine residues and RNase T 1 hydrolysing at guanine residues were used to hydrolyse the RNA. [29, 38] The DNA samples were initially hydrolysed to 2′-deoxynucleoside 3′-monophosphates by an overnight incubation with a combination of an endoexonuclease (micrococcal nuclease) and 5′-exonuclease (calf spleen phosphodiesterase). The 2′-deoxynucleosides were generated by cleavage of the phosphate group following incubation with a 3′-nucleotidase (nuclease P1) for 4 h.
The hydrolysed DNA samples were analysed using reverse phase HPLC-UV detection that allowed for the separation of 5-MedC and dC from the remaining three 2′-deoxynucleosides present in DNA. In principle the HPLC-UV approach used was similar to previously published methods. [25] [26] [27] [28] [29] 
Conclusion
The development of a relatively straightforward and cost effective HPLC-UV detection method has been described for the accurate assessment of 5-MedC content in genomic DNA. 
